Grade My Investments
Home › Free Stock Grades › LUCY

Lucyd, Inc (LUCY) Stock Grade

LUCY · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$6.0M
P/E Ratio
—
Revenue Growth (YoY)
+62.7%
Net Margin
-285.2%
Return on Equity
—
Dividend Yield
None

About Lucyd, Inc's fundamentals

Lucyd, Inc is a micro-cap healthcare company with a market capitalization of $6.0 million that is experiencing strong revenue growth of 62.7% year-over-year, indicating expanding sales in the medical instruments and supplies sector. However, the company is currently unprofitable, reporting a net margin of -285.2% and a net loss in its latest annual statement, meaning it is spending significantly more than it generates in revenue. The company does not pay a dividend and lacks sufficient profitability metrics to calculate a P/E ratio or return on equity, reflecting its early-stage or turnaround status.

Track LUCY free — no credit card required. Live grade + monthly AI report →